GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Huapont Life Science Co Ltd (SZSE:002004) » Definitions » Total Assets

Huapont Life Science Co (SZSE:002004) Total Assets : ¥31,479 Mil (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Huapont Life Science Co Total Assets?

Huapont Life Science Co's Total Assets for the quarter that ended in Mar. 2024 was ¥31,479 Mil.

During the past 12 months, Huapont Life Science Co's average Total Assets Growth Rate was 4.20% per year. During the past 3 years, the average Total Assets Growth Rate was 4.20% per year. During the past 5 years, the average Total Assets Growth Rate was 3.90% per year. During the past 10 years, the average Total Assets Growth Rate was 12.20% per year.

During the past 13 years, Huapont Life Science Co's highest 3-Year average Total Assets Growth Rate was 75.00%. The lowest was 2.30%. And the median was 28.10%.

Total Assets is connected with ROA %. Huapont Life Science Co's annualized ROA % for the quarter that ended in Mar. 2024 was 2.00%. Total Assets is also linked to Revenue through Asset Turnover. Huapont Life Science Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.09.


Huapont Life Science Co Total Assets Historical Data

The historical data trend for Huapont Life Science Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huapont Life Science Co Total Assets Chart

Huapont Life Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26,636.40 28,262.69 30,039.67 30,029.43 30,727.40

Huapont Life Science Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30,225.56 30,427.59 30,375.91 30,727.40 31,479.04

Huapont Life Science Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Huapont Life Science Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=16584.733+14142.663
=30,727

Huapont Life Science Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=16777.976+14701.068
=31,479

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huapont Life Science Co  (SZSE:002004) Total Assets Explanation

Total Assets is connected with ROA %.

Huapont Life Science Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=622.24/( (30727.397+31479.044)/ 2 )
=622.24/31103.2205
=2.00 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Huapont Life Science Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=2915.49/( (30727.397+31479.044)/ 2 )
=2915.49/31103.2205
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Huapont Life Science Co Total Assets Related Terms

Thank you for viewing the detailed overview of Huapont Life Science Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Huapont Life Science Co (SZSE:002004) Business Description

Traded in Other Exchanges
N/A
Address
No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
Executives
Zhang Hai An Directors, executives
Wang Rong Director
Yu Jun Tian Director
Zhang Song Shan Directors, executives
Chen Zhi Securities Affairs Representative
Jiang Kang Wei Director
Lv Li Ming Director
Li Sheng Xue Director
Luo Da Lin Supervisors
Li Zhi Directors, executives
Tian Song Min Executives
Wu Bi Zhong Director
Yu Yun Jian Supervisors
Gu Chuan Wei Supervisors

Huapont Life Science Co (SZSE:002004) Headlines

No Headlines